Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:zaleplon
|
| gptkbp:approvalYear |
1999
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:N05CF03
|
| gptkbp:brand |
gptkb:zaleplon
|
| gptkbp:contraindication |
severe liver impairment
|
| gptkbp:drugClass |
nonbenzodiazepine hypnotic
|
| gptkbp:eliminatedIn |
renal
|
| gptkbp:form |
gptkb:tablet
capsule |
| gptkbp:halfLife |
1 hour
|
| https://www.w3.org/2000/01/rdf-schema#label |
SONATA
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedFor |
insomnia
|
| gptkbp:bfsParent |
gptkb:Blue_Brain_Project
|
| gptkbp:bfsLayer |
6
|